跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
AT-20
首页
药物
AT-20
AT-20
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Method of manufacturing T-20 and T-1249 peptides at commercial scale, and T-20 and T-1249 compositions related thereto
申请人: ROHM & HAAS
优先权: 2003
CN
EP
2 件公开
Method of manufacturing polypeptides, including T-20 and T-1249, at commercial scale, and polypeptide compositions related thereto
申请人: BOHLING JAMES CHARLES
优先权: 2004
US
Electroporation process for delivering a composition comprising at least one peptide of molecular weight ranging from 500 Da to 20 kDa
申请人: OREAL
优先权: 2021
CN
US
2 件公开
Efficient Process for Preparing Steroids and Vitamin D Derivatives With the Unnatural Configuration at C20 (20 Alpha-Methyl) from Pregnenolone
申请人: QUATRX PHARMACEUTICALS CO
优先权: 2008
US
Monounsaturated fatty acids of at least 20 carbon atoms and perhydrocyclopentanophenanthrene nucleus combination molecules and their use as weight-loss agents
申请人: GIROUARD MICHAEL P
优先权: 2002
US
2 件公开
Dyeing or lightening process using a composition rich in fatty substances comprising an alcohol having at least 20 carbons, compositions and device
申请人: RAPOLD PHILIPPE
优先权: 2012
US
2 件公开
FLUORENE DIMERS AND TRIMERS
申请人: GEN ELECTRIC
优先权: 2009
US
HONEY-CANNABINOID THERAPEUTIC COMPOSITION
申请人: CANABUZZ MED
优先权: 2015
EP
US
3 件公开
药物
反馈